{
  "meta": {
    "title": "Neet_Pg_2025",
    "url": "https://brainandscalpel.vercel.app/neet-pg-2025-466ee8c1.html",
    "scrapedAt": "2025-11-30T07:34:09.059Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Vecuronium</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Atracurium</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Cis-atracurium</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancuronium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Following administration of a muscle relaxant, the patient develops erythema, flushing and a drop in blood pressure. Which of the following agents is most likely responsible?</span></p>",
      "unique_key": "DT1325316",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325316,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The given features of erythema, flushing and drop in blood pressure developing after administration of a muscle relaxant point to the use of <strong>atracurium</strong>.</p>\n<ul>\n<li><strong>Atracurium</strong> is a <strong>non-depolarising muscle relaxant</strong> with intermediate duration.</li>\n<li>It undergoes metabolism through<strong> plasma esterases</strong> and spontaneous degradation in plasma and tissues via <strong>Hofmann elimination</strong>, producing less-active metabolites.</li>\n<li>Due to this, it does not show prolonged elimination half-life in patients with <strong>renal impairment</strong>, making it a suitable choice in such cases.</li>\n<li>Atracurium can trigger <strong>histamine release</strong>, potentially causing bronchospasm, <strong>hypotension</strong>, and increased bronchial and salivary secretions, though the effect is less pronounced than with tubocurarine unless injected rapidly.</li>\n<li><strong>Cisatracurium</strong>, the cis-isomer, is metabolised similarly but is more potent than atracurium and does not cause histamine release. <strong>(Option C ruled out)</strong></li>\n<li>Neuromuscular blocking agents are broadly categorised into <strong>depolarising </strong>and <strong>competitive (non-depolarising)</strong> types.</li>\n<li>Currently,<strong> succinylcholine</strong> is the only depolarising agent widely used in clinical practice, while several competitive/nondepolarizing agents are available.</li>\n<li>Their primary applications include aiding endotracheal intubation and providing skeletal muscle relaxation during surgical procedures.</li>\n<li>Some of the nondepolarizing agents classified according to their duration of action are given in the table below. </li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250910ec4c0e7e-d25a-41da-b753-e5b0247bb211.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Vecuronium (Option A): </strong>Vecuronium, a non-depolarising muscle relaxant of intermediate duration, is not commonly associated with histamine release. It undergoes hepatic and renal elimination.</p>\n<p><strong>Pancuronium (Option D): </strong>Pancuronium, an amino-ester, is a long-acting competitive muscle relaxant that is not frequently associated with histamine release. It exhibits antimuscarinic receptor activity, is eliminated via both the kidneys and liver, and its <strong>vagolytic effects</strong> can lead to <strong>tachycardia</strong>, <strong>hypertension</strong>, and increased cardiac output.</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Dantrolene</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Paracetamol</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium chloride</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old male undergoing abdominal surgery under general anaesthesia developssudden generalised muscle rigidity, rapid increase in body temperature, and tachycardia shortly after administration of sevoflurane and succinylcholine. His end-tidal CO<sub>2</sub> is rising despite controlled ventilation. What is the most appropriate immediate treatment?</span></p>",
      "unique_key": "DT1325317",
      "question_audio": null,
      "question_video": null,
      "map_id": 1325317,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The given clinical features of muscle rigidity, increasing body temperature, and tachycardia after administration of succinylcholine and sevoflurane (inhalational anaesthetic agent) is suggestive of <strong>malignant hyperthermia,</strong> for which the immediate treatment consists of administration of <strong>dantrolene</strong>.</p>\r\n<p>The features of malignant hyperthermia are summarised in the table given below. </p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509101963ee3f-1811-42de-9677-008be0bc2d48.png\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509102507a40b-5216-4734-88a3-60a077418081.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Paracetamol (Option B): </strong>Fever can be managed by giving<strong> iced fluids</strong>, cooling the skin surface, cooling internal body cavities with sterile fluids, and, if needed, using a heat exchanger connected to a pump oxygenator. Paracetamol is not commonly used.</p>\r\n<p><strong>Propranolol (Option D): </strong>Not commonly used in the management of malignant hyperthermia.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}